Dihydrothienopyrimidines for the treatment of inflammatory...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 495/04 (2006.01) A61K 31/519 (2006.01) A61P 11/00 (2006.01)

Patent

CA 2605161

The invention relates to novel dihydrothienopyrimidines of formula (1) as well as pharmaceutically acceptable salts, diastereomers, enantiomers, racemates, hydrates, or solvates thereof, which are suitable for the treatment of ailments or diseases of the respiratory tract, gastrointestinal ailments or diseases, inflammatory diseases of the joints, skin, or eyes, diseases of the peripheral or central nervous system, or cancer diseases. Also disclosed are pharmaceutical compositions containing the inventive compounds.

L'invention concerne de nouvelles dihydrothiénopyrimidines de la formule (1) et leurs sels pharmacologiquement compatibles, diastéréomères, énantiomères, racémates, hydrates ou solvates, qui conviennent au traitement de maux ou maladies des voies respiratoires ou de la région gastro-intestinale, de maladies inflammatoires des articulations, de la peau ou des yeux, de maladies du système nerveux périphérique ou central ou de cancers. L'invention concerne également des compositions pharmaceutiques contenant ces composés.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Dihydrothienopyrimidines for the treatment of inflammatory... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dihydrothienopyrimidines for the treatment of inflammatory..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dihydrothienopyrimidines for the treatment of inflammatory... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1904030

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.